InvestorsHub Logo
icon url

PGG76109

06/07/14 1:36 PM

#179184 RE: Couch #179181

You know he has NADA why ask?
Bavi will succeed that's all I know. PG
icon url

Frustrated

06/07/14 3:08 PM

#179192 RE: Couch #179181

Quote:
The new reconfigured data is obviously not as good as the data originally reported.

Do you have one single solitary shred of evidence to back this up?


Absolutely, All you have to do is compare the poster session data with the original PR and compare the MOS numbers and all the data. It is rather plain and simple.
icon url

Protector

06/07/14 7:33 PM

#179217 RE: Couch #179181

Couch, I think that statement of Frustrated is 100% correct.

PPHM went to the FDA with PII SOC improvement of 60% (the reconfigured data) while the original reported data was 113+%.

I don't think there is any need of prove because PPHM said BOTH themselves. Dr. Brekken did say at NYAS in the Q&A that the data is indeed better then the data send to the FDA, but we new that because the dose switching was NOT in favour of Bavi but in its disadvantage. This means the real results are BETTER then 113% and that they were STAT SIG in PII. I cannot emphasize that last point sufficiently!!!